Metaplastic Breast Cancer is a rare malignancy characterized by the presence of two or more cellular types, usually a mix of epithelial and mesenchymal components. This type of breast cancer represents 1% of all breast cancers diagnosed annually and traditional chemotherapy and hormonal therapies generally are ineffective against MpBC and often associate with a poor survival rate.

Due to its rarity and lack of treatment options these funds will help in a global effort to link specific oncology researchers and the patients that desperately need more updated and advanced treatments including clinical trials. It is a vital need to compile a world wide patient data registry and the researchers that have the most updated treatment options.